Filana Therapeutics, Inc.FLNA

$1.22+0.01 (+0.83%)

NASDAQHealthcare24:00 UTC

Company snapshot

Market Cap

$59M

Micro-cap

-27%

2026 — today

10-Year Price

-27%

2026 — today

52-Week Range

$1.18$2.45

Current $1.22· 3%

Filana Therapeutics, Inc. is a company dedicated to pioneering new pharmaceutical products and diagnostic technologies. A key area of its research is focused on creating potential treatments for Alzheimer's disease, including the investigational compounds PTI-125 and PTI-125Dx. Established by Remi Barbier in May 1998, the firm maintains its principal office in Austin, Texas.

Valuation in context

P/E ratio

-0.8

N/A

Not meaningful — company is unprofitable

P/B ratio

0.9

Near historic low

Near historic low — last 10 years

Free · No credit card needed

Get alerted when FLNA is cheap

Set a free alert — we'll push you when P/E, yield, or other metrics cross a historical threshold.